Fierce Pharma

DECEMBER 12, 2023

Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. | Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages. Inclusion in the list doesn’t mean a particular drug is likely to experience a shortage anytime soon, the EMA said.

Medicine 360

Medicine Doctors Government Patients 360

MedCity News

DECEMBER 12, 2023

The Lower Costs, More Transparency Act has passed in the House with bipartisan support. The action is being applauded from several advocacy organizations.

Prescription 128

Prescription 128

Fierce Pharma

DECEMBER 12, 2023

To complete its acquisition of Seagen, what did Pfizer need to do to satisfy antitrust concerns of the Federal Trade Commission? | By agreeing to donate royalties on its U.S. sales of bladder cancer drug Bavencio, Pfizer has received the go-ahead to finalize its $43 billion buyout of Seagen, the company said on Tuesday. Pfizer expects to close the merger on Thursday.

Sales 317

Sales 317

MedCity News

DECEMBER 12, 2023

Sanofi, which markets the two primary treatments for Pompe disease, was trying to add a third one by licensing rights to a Maze Therapeutics drug candidate with a different therapeutic approach. A Federal Trade Commission complaint alleges the deal amounts to a monopoly player taking out its competition.

Competition 124

Competition Marketing Biopharma Pharma 124

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 12, 2023

Genentech’s brief leadership interregnum is coming to an end as the company’s interim chief executive, Ashley Magargee, prepares to take a permanent place on the throne. | Genentech veteran Ashley Magargee, who was tapped to temporarily steer the Roche subsidiary in November, will don the mantle of full-time CEO on Jan. 1, 2024. The executive move comes amid a period of C-suite fluidity for Roche and its large pharma group.

Pharma 298

Pharma 298

MedCity News

DECEMBER 12, 2023

During the first three quarters of 2023, the prices for CMS’ 500 shoppable services increased by 2.0%, according to a new report. This figure is in alignment with the 1.9% U.S. inflation measured by the Personal Consumption Expenditures Price Index and below the overall U.S. inflation rate measured by the Consumer Price Index.

Healthcare 124

Healthcare Healthcare 124

European Pharmaceutical Review

DECEMBER 12, 2023

Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. He discusses why NK cell therapy’s ability to generate ‘synthetic immunity’ in the body means this modality holds potential as an anti-cancer treatment.

Pharma 124

Pharma Engineering Safety Patients 124

Fierce Pharma

DECEMBER 12, 2023

As waves of layoffs continue to hit the biopharma industry, Ferring Pharmaceuticals is trimming its headcount by 134 across its two U.S. locations. | The drugmaker will lay off 79 at its New Jersey headquarters and 55 at its microbiome subsidiary Rebiotix in Minnesota as a result of a "revised business strategy.

Biopharma 264

Biopharma Pharmaceutical 264

MedCity News

DECEMBER 12, 2023

The integration of AI into cardiology workflows can help triage care automatically, ensuring the right physicians weigh in on patient data at the right time which may potentially improve clinical outcomes for all patients in need.

Physicians 119

Physicians Patients 119

Fierce Pharma

DECEMBER 12, 2023

After multiple expansion forays overseas this year, biomanufacturing outfit National Resilience is returning to its American roots with plans to beef up production and add hundreds of new jobs at a | Resilience is expanding operations at the West Chester, Ohio, facility it bought from AstraZeneca in January, the technology-focused contract manufacturer said Monday.

Manufacturing 263

Manufacturing 263

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

DECEMBER 12, 2023

Zocdoc Founder and CEO Oliver Kharraz gave five predictions about how patient preferences will evolve in 2024. Some of them include Americans increasingly seeking cash-pay care options and an uptick in patients seeking mental health appointments before and after the presidential election.

Patients 119

Patients 119

Fierce Pharma

DECEMBER 12, 2023

With the initial shock of AbbVie and Johnson & Johnson's disease-specific approval pull for Imbruvica now fading into the rearview, the partners are making the case for the BTK inhibitor to sta | With the initial shock of AbbVie and Johnson & Johnson's disease-specific approval pull for Imbruvica now fading into the rearview, the partners are making the case for the BTK inhibitor to stage a comeback in mantle cell lymphoma.

258

258

MedCity News

DECEMBER 12, 2023

AstraZeneca is acquiring Icosavax, which has technology well-suited for multivalent vaccines. Icosavax’s pipeline includes a Phase 3-ready program that protects against two pathogens that cause severe respiratory infections in older adults.

Biopharma 118

Biopharma Pharma 118

Fierce Pharma

DECEMBER 12, 2023

Another data face-off between the two anti-CD38 multiple myeloma drugs—Johnson & Johnson’s Darzalex and Sanofi’s Sarclisa—took place at the 65th American Society of Hematology meeting. | Another data face-off between the two anti-CD38 multiple myeloma drugs—J&J's Darzalex and Sanofi's Sarclisa—took place at the ASH conference. Both regimens showed strong efficacy in newly diagnosed patients, but only one result is considered practice-changing right now.

Patients 245

Patients 245

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

DECEMBER 12, 2023

Talkspace is offering free self-guided mental health content to some female Evernow customers over the age of 40, while Evernow is offering discounted menopause care to Talkspace patients.

Patients 118

Patients 118

pharmaphorum

DECEMBER 12, 2023

BMS bolts on SystImmune bispecific ADC in $8.4bn deal Phil.

111

111

MedCity News

DECEMBER 12, 2023

In the last episode of the year, Wrobel, CEO of an Indiana-based federally qualified health center, describes how a survey helped her and her community workers understand exactly how confident her patients are in managing their own care and the best way to help them with the ultimate goal of improving overall health equity.

Patients 115

Patients Management 115

pharmaphorum

DECEMBER 12, 2023

ASH: Sanofi’s Sarclisa carves out a multiple myeloma niche Phil.

110

110

Advertisement

MedCity News

DECEMBER 12, 2023

Integrations are incredibly destabilizing and stressful for impacted employees, as well as for those who “survive.” Organizations that are worth acquiring are successful and attractive because they are comprised of smart, talented people who have created that success.

111

111

pharmaphorum

DECEMBER 12, 2023

Genentech confirms Magargee as permanent CEO Phil.

110

110

MedCity News

DECEMBER 12, 2023

While there will never be a perfect solution to preventing drug diversion 100% of the time, leveraging the right people, processes and technology is our best chance of keeping patients safe.

Patients 110

Patients Biopharma 110

PharmaTimes

DECEMBER 12, 2023

Around 240 million children worldwide are living with these types of disorders - News - PharmaTimes

106

106

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

DECEMBER 12, 2023

Digitised pathology resource will speed HIV cancer R&D Phil.

105

105

European Pharmaceutical Review

DECEMBER 12, 2023

The first stage of construction has officially begun on Lek Pharmaceuticals’ new biologics and biosimilars production centre in Lendava, north eastern Slovenia. Representing the largest foreign direct investment in Slovenia, the launch of the $400 million centre was attended by key Slovenian representatives, including the Prime Minister, Robert Golob.

Pharmaceutical 105

Pharmaceutical Manufacturing Medicine 105

pharmaphorum

DECEMBER 12, 2023

Sanofi abandons Maze Pompe deal after FTC lawsuit Phil.

105

105

European Pharmaceutical Review

DECEMBER 12, 2023

The US Food and Drug Administration (FDA) has approved two landmark cell-based gene therapies for treatment of inherited blood disorder sickle cell disease. Casgevy (exagamglogene autotemcel) a cell-based gene therapy, is approved for the treatment of sickle cell disease in patients 12 years of age and older with recurrent vaso-occlusive crises (VOCs).

Food and Drug Administration 105

Food and Drug Administration FDA Safety Food 105

Advertisement

Distribution

pharmaphorum

DECEMBER 12, 2023

AZ agrees $1.1bn deal to buy RSV jab developer Icosavax Phil.

105

105

PharmExec

DECEMBER 12, 2023

While hurdles remain, home healthcare could deliver better patient-centered cancer care—providing improved outcomes, enhanced quality of life, and reduced strain on resources.

Healthcare 105

Healthcare Healthcare Patients 105

Pharmaceutical Commerce

DECEMBER 12, 2023

Bayer executive talks Enable Holistic Hub and Provider Services panel.

105

105

PharmExec

DECEMBER 12, 2023

Experts gauge whether the needle is finally moving on the effective structuring of outcomes centered payment agreements—from operational, technology, and acceptance standpoints.

Pharma 103

Pharma 103

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales